A real-world prospective analysis of the relationship between nanoliposomal irinotecan and fluorouracil with folinic acid and neutropenia in patients with pancreatic cancer (NAPOLEON-2 study, NN-2401).

被引：0
作者：
Shirakawa, Tsuyoshi
Araki, Tomonori
Shimokawa, Mototsugu
Otsuka, Taiga
Nakazawa, Junichi
Shimokawa, Hozumi
Koga, Futa
Oda, Hisanobu
Takeshita, Shigeyuki
Arima, Shiho
Arita, Shuji
Kawaguchi, Yasunori
Nishikawa, Kazuo
Taguchi, Hiroki
Jikuya, Kenichi
Sakai, Tatsunori
Ueda, Yujiro
Sakae, Takahiro
Mizuta, Toshihiko
Mitsugi, Kenji
机构：
[1] Clin Hematol Oncol Treatment Study Grp, Fukuoka, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan
[4] Minato Med Clin, Tokyo, Japan
[5] Kagoshima City Hosp, Kagoshima, Japan
[6] Japan Community Healthcare Org, Kitakyushu, Fukuoka, Japan
[7] Saga Med Ctr Koseikan, Saga, Japan
[8] Saiseikai Kumamoto Hosp, Kumamoto, Japan
[9] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[10] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan
[11] Miyazaki Prefectural Miyazaki Hosp, Miyazaki, Japan
[12] Asakura Med Assoc Hosp, Asakura, Japan
[13] Oita Univ, Fac Med, Yufu, Japan
[14] Imakiire Gen Hosp, Kagoshima, Japan
[15] Natl Hosp Org, Kumamoto, Japan
[16] Japanese Red Cross Kumamoto Hosp, Kumamoto, Japan
[17] Saiseikai Sendai Hosp, Satsumasendai, Japan
[18] Fujikawa Hosp, Saga, Japan
[19] Sasebo Kyosai Hosp, Sasebo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：762 / 762
页数：1
相关论文
共 28 条
[21]   A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX) [J].
Atkins, Katelyn Mae ;
Gong, Jun ;
Tighiouart, Mourad ;
Klempner, Samuel J. ;
Tuli, Richard ;
Placencio-Hickok, Veronica ;
Hendifar, Andrew Eugene .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[22]   A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX). [J].
Hendifar, Andrew Eugene ;
Kim, Sungjin ;
Tighiouart, Mourad ;
Hautamaki, Emily ;
Kim, Haesoo ;
Ng, Camille ;
Liu, Jar-Yee ;
Scher, Kevin S. ;
Klempner, Samuel J. ;
Placencio-Hickok, Veronica ;
Gresham, Gillian ;
Gong, Jun .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23]   Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group [J].
Yoo, Changhoon ;
Im, Hyeon-Su ;
Kim, Kyu-pyo ;
Oh, Do-Youn ;
Lee, Kyung-Hun ;
Chon, Hong Jae ;
Kim, Joo Hoon ;
Kang, Myoungjoo ;
Kim, Ilhwan ;
Lee, Guk Jin ;
Oh, Sung Yong ;
Choi, Younak ;
Choi, Hye Jin ;
Kim, Seung Tae ;
Park, Joon Oh ;
Ryoo, Baek-Yeol .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
[24]   Observational retrospective evaluation of treatment with liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic cancer patients: An Italian large real-world analysis [J].
Pellino, Antonio ;
Manai, Chiara ;
Merz, Valeria ;
Scartozzi, Mario ;
Milella, Michele ;
De Vita, Ferdinando ;
Antonuzzo, Lorenzo ;
Zichi, Clizia ;
Satolli, Maria Antonietta ;
Panebianco, Michele ;
Noventa, Silvia ;
Giordano, Guido ;
Nappo, Floriana ;
Zecchetto, Camilla ;
Puzzoni, Marco ;
Vaccaro, Vanja ;
Pappalardo, Annalisa ;
Giommoni, Elisa ;
Melisi, Davide ;
Lonardi, Sara .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[25]   Irinotecan liposome-based regimen in Chinese patients with advanced pancreatic cancer: A prospective, multi-center, observational real-world study [J].
Xu, J. ;
Jiang, K. ;
Lu, H. ;
Gong, X. ;
Li, H. ;
Wu, Y. ;
Chen, L. ;
Liu, W. ;
Wu, D. ;
Du, J. ;
Sun, L. ;
Zhao, Y. ;
Dai, E. ;
An, H. ;
Liu, Y. ;
Wang, X. ;
Liu, Q. ;
Yu, X. .
ANNALS OF ONCOLOGY, 2024, 35 :S1500-S1500
[26]   Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study) [J].
Koga, Futa ;
Kawaguchi, Yasunori ;
Shimokawa, Mototsugu ;
Murayama, Kenichiro ;
Nakashita, Shunya ;
Oza, Noriko ;
Ureshino, Norio ;
Takahashi, Hirokazu ;
Ueda, Yujiro ;
Nakazawa, Junichi ;
Komori, Azusa ;
Otsu, Satoshi ;
Arima, Shiho ;
Fukahori, Masaru ;
Makiyama, Akitaka ;
Taguchi, Hiroki ;
Honda, Takuya ;
Shibuki, Taro ;
Nio, Kenta ;
Ide, Yasushi ;
Mizuta, Toshihiko ;
Shirakawa, Tsuyoshi ;
Otsuka, Taiga ;
Mitsugi, Kenji .
JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) :82-87
[27]   Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies [J].
Araki, Tomonori ;
Kawahira, Machiko ;
Shimokawa, Mototsugu ;
Otsuka, Taiga ;
Hayashi, Kohei ;
Sonoda, Yuki ;
Honda, Takuya ;
Nakao, Kazuhiko ;
Shibuki, Taro ;
Nakazawa, Junichi ;
Arima, Shiho ;
Fukahori, Masaru ;
Miwa, Keisuke ;
Koga, Futa ;
Ueda, Yujiro ;
Kubotsu, Yoshihito ;
Makiyama, Akitaka ;
Shimokawa, Hozumi ;
Takeshita, Shigeyuki ;
Nishikawa, Kazuo ;
Komori, Azusa ;
Otsu, Satoshi ;
Hosokawa, Ayumu ;
Sakai, Tatsunori ;
Oda, Hisanobu ;
Arita, Shuji ;
Taguchi, Hiroki ;
Tsuneyoshi, Kengo ;
Kawaguchi, Yasunori ;
Fujita, Toshihiro ;
Sakae, Takahiro ;
Nio, Kenta ;
Ide, Yasushi ;
Ureshino, Norio ;
Shirakawa, Tsuyoshi ;
Mizuta, Toshihiko ;
Mitsugi, Kenji .
ONCOLOGY, 2025, 103 (07) :569-579
[28]   Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2-advanced breast cancer: Final analysis of TreatER plus ight, a Canadian prospective, real-world, observational study [J].
Doyle, Catherine ;
Lohmann, Ana Elisa ;
Iqbal, Nayyer ;
Henning, Jan-Willem ;
Kulkarni, Swati ;
Califaretti, Nadia ;
Hilton, John ;
Ferrario, Cristiano ;
Bouganim, Nathaniel ;
Mates, Mihaela ;
Guillemette, Stephanie ;
Leite, Ricardo ;
Chia, Stephen .
CANCER RESEARCH, 2024, 84 (09)
123